Uniqure B.V. buy melinda
Start price
27.06.17
/
50%
€5.41
Target price
18.07.17
€6.13
Performance (%)
7.52%
End price
18.07.17
€5.82
Summary
This prediction ended on 18.07.17 with a price of €5.82. The BUY prediction by melinda finished with a performance of 7.52%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Uniqure B.V. | 7.573% | 7.573% | -77.039% | -82.876% |
iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
According to melinda what are the pros and cons of Uniqure B.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Uniqure B.V. diskutieren
Gesundheit | Biotechnologie | Niederlande
Aktualisiert Phase 1/2 nach dem Kongress der Internationalen Gesellschaft für Thrombose und Hämostase (ISTH) 2017, die 11. Juli 2017. Phase - 2b - Studie zu Q3 2017 beginnen.
(Vom Mitglied beendet)
Stopped prediction by melinda for Uniqure B.V.
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€32.45
29.08.20
29.08.20
€40.00
04.11.21
04.11.21
-7.18%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€38.10
30.08.18
30.08.18
€40.59
25.02.19
25.02.19
31.53%
25.02.19
25.02.19
Could be worthwhile Investment >10% per year